Trade PASG stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Passage Bio, Inc. (PASG) is trading at US$4.86, down 2.80% today as of Sep 14, 16:00 EDT. The company has a market capitalisation of US$14.29M. Over the past 52 weeks, PASG has traded between US$3.29 and US$20.00. On Syfe you can trade PASG with $0 commission and add it to your watchlist.
| Previous close | US$5.00 |
|---|---|
| Market cap | US$14.29M |
| 52-week range | US$3.29 – US$20.00 |
| Volume | 30.12K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Passage Bio, Inc.
Passage Bio, Inc. operates as a genetic medicines company. It focuses on development of therapies for central nervous system disorders. The company was founded by Stephen P. Squinto, Tadataka Yamada, David A. Socks, Aditya Kohli, and James M. Wilson in July 2017 and is headquartered in Philadelphia, PA.
Year: 2020
Top Premarket Decliners
Jun 25, 11:40 AM · MT Newswires
Passage Bio, Remix Therapeutics Plan All-Stock Merger
Jun 24, 9:04 PM · MT Newswires
Sector Update: Health Care Stocks Softer Late Afternoon
Apr 21, 7:57 PM · MT Newswires
Sector Update: Health Care
Apr 21, 7:35 PM · MT Newswires
Passage Bio Faces Tougher FDA Road After Trial Shift, Wedbush Says
Apr 21, 6:20 PM · MT Newswires
Passage Bio, Inc. (PASG) stock is trading at US$4.86, -2.80% from the previous close of US$5.00.
The market cap for Passage Bio, Inc. (PASG) stock is approximately US$14.29M.
The 52-week high for Passage Bio, Inc. (PASG) stock is US$20.00.
The 52-week low for Passage Bio, Inc. (PASG) stock is US$3.29.
Passage Bio, Inc. (PASG) does not currently pay a dividend.
Stay on top of PASG
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
